Variables | Number of patients N (%) |
---|---|
Age (years) | |
 Mean ± SD | 47.9 ± 11 |
 Extremes | 24–90 |
Menopausal status | |
 Premenopause | 355 (58.4) |
 Postmenopause | 253 (41.6) |
Histologic type | |
 IDC-NST | 511(84.1) |
 Lobular | 30 (4.9) |
 Other | 67 (11) |
Nottingham grade | |
 I | 100 (19.5) |
 II | 307 (59.8) |
 III | 106 (20.7) |
 Indetermined | 95 (00) |
ER | |
 Positive | 334 (54.9) |
 Negative | 274 (45.1) |
PR | |
 Positive | 252 (41.5) |
 Negative | 356 (58.5) |
HER2 | |
 Positive | 105 (17.3) |
 Negative | 472 (77.6) |
 Equivocal | 31(5.1) |
ER/PR | |
 ER/PR+ | 356 (58.5) |
 ER/PR- | 252 (41.5) |
Molecular subtype | |
 Luminal A | 268 (46.4) |
 Luminal B | 68 (11.8) |
 HER2 enriched | 37 (6.4) |
 Triple negative | 204 (35.4) |